Enhanced functional performance characteristics of a new polysulfone membrane for high-flux hemodialysis

Blood Purification

Volumn 20, Issue 4, 2002, Pages 325-333

  Klingel, Reinhard ^a,d   Ahrenholz, Peter ^b   Schwarting, Andreas ^d   Röckel, Arnold ^c  

^a Apheresis Research Institute   (Germany)

^b BioArtProducts GmbH   (Germany)

^c DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Dialysis membrane; High flux hemodialysis; Polysulfone

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; BETA 2 MICROGLOBULIN; COMPLEMENT COMPONENT C3A; LEUKOCYTE ELASTASE; MYOGLOBIN; POLYSULFONE; PROLACTIN;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; IN VIVO STUDY; LEUKOCYTE COUNT; MOLECULAR WEIGHT; PERFORMANCE; PRIORITY JOURNAL; SOLUTE; THROMBOCYTE COUNT; UREMIA;

ADULT; AGED; AREA UNDER CURVE; BIOCOMPATIBLE MATERIALS; BLOOD PROTEINS; HEMATOLOGIC TESTS; HUMANS; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PERMEABILITY; POLYMERS; RENAL DIALYSIS; SERUM ALBUMIN; SULFONES;

EID: 0036060433     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063099     Document Type: Article

References (41)

1. Relationship of dialysis membrane and cause-specific mortality
2. Effect of the dialysis membrane on mortality of chronic hemodialysis patients
3. The dose of hemodialysis and patient mortality
4. Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival
5. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients
6. Comparison of mortality in ESRD patients on convective and dissusive extracorporeal treatments
7. Online haemodiafiltration versus low-flux hemodialysis. A prospective randomized study
8. Solute fluxes in different treatment modalities
9. Improved outcome for hemodialysis patients treated with high-flux membranes
10. The removal of uraemic toxins
11. p-Cresol: A toxin revealing many neglected but relevant aspects of uraemic toxicity
12. Protein permeability in dialysis
13. Influence of convection on small molecule clearances in online hemodiafiltration
14. A comparison of three brands of polysulfone membranes
15. Increasing dialysate flow rate increases dialyzer urea mass transfer-area coefficienbts during clinical use
16. Pyrogen retention by the Asahi APS-650 polysulfone dialyze during in vitro dialysis with whole human donor blood
17. Dialyzer permeability for low molecular weight proteins
18. Laboratory control of minmal heparinization during hemodialysis in patients with a risk of hemorrhage
19. Principles and biophysics of dialysis
20. Measurement of solute balance during dialysis therapy
21. Statistical aspects of the design and analysis of studies to compare heamodialysis membranes
22. Influence of the dialysis membrane on outcome of ESRD patients
23. Haemodialyzers and associated devices
24. Clinical manifestations of AB-amyloidosis: Effects of biocompatibility and flux
25. Association of serum phosphorous and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
26. Phosphate removal and hemodialysis conditions
27. Treatment modalities in comparison: When do clinical differences emerge?
28. Albumin loss with high-flux dialysis membranes is negligible
29. Determinants of haemodialyser performance and the potential effect on clinical outcome
30. High-flux hemodialysis membranes improve lipid profile in chronic hemodialysis patients
31. Genesis of the uraemic syndrome-role of uraemic toxins
32. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of carbonyl stress
33. Effect of uraemia and dialysis modality on mononuclear cell apoptosis
34. β2-Microglobulin-derived amyloidosis: An update
35. Turnover in humans of β2-microglobulin-the constant chain of HLA-antigens
36. Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients
37. Importance of hyperlipidaemia and therapy in renal patients
38. Advanced glycation and lipoxidation end products-role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism
39. Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis
40. Effect of biocompatibility of hemodialysis membranes on serum albumin levels
41. Rhabdomyolysis